SCHEMBL9924272

SCHEMBL9924272

O=C(/N=C(/NCc1ccc(Cl)cc1F)N[C@H]1CC[C@H](O)CC1)c1ccc(F)c(F)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RX7 Q99572 5/20 0.41
ROCK2 O75116 2/20 0.39
ROCK1 Q13464 1/20 0.39
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C9 P11712 1/20 0.37
KCNH2 Q12809 1/20 0.37
NR1H4 Q96RI1 1/20 0.37
HTR7 P34969 1/20 0.37
MC5R P33032 1/20 0.37
HTR2C P28335 1/20 0.36
HTR2B P41595 1/20 0.36
MCHR1 Q99705 1/20 0.36
TRPV1 Q8NER1 1/20 0.36
ANO1 Q5XXA6 1/20 0.35
ERCC1 P07992 1/20 0.35
ERCC4 Q92889 1/20 0.35
MEN1 O00255 1/20 0.35
ALDH1A1 P00352 1/20 0.35
LMNA P02545 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9924243 0.91 P2RX7 (0.39) P2RX7NR1H4MCHR1MEN1ALDH1A1
SCHEMBL9924271 0.89 P2RX7 (0.43) P2RX7
SCHEMBL17206627 0.88 KMT2A (0.42) MCHR1MEN1ALDH1A1LMNAHPGD
SCHEMBL9924426 0.88 EPHX1 (0.44) CYP3A4CYP2D6CYP2C9KCNH2NR1H4
SCHEMBL9924064 0.87 CHRM1 (0.40) P2RX7ROCK2ROCK1CYP2C9HTR7
SCHEMBL9924151 0.86 EPHX2 (0.48) P2RX7ROCK2ROCK1HTR2BMCHR1
SCHEMBL9924237 0.86 SIGMAR1 (0.39) ROCK2ROCK1CYP2C9KCNH2HTR7
SCHEMBL9924241 0.85 SSTR3 (0.40) P2RX7ROCK2ROCK1KCNH2HTR7
SCHEMBL9924238 0.84 P2RX7 (0.40) P2RX7MCHR1MEN1ALDH1A1KMT2A
SCHEMBL9924268 0.84 SSTR3 (0.46) CYP3A4CYP2D6CYP2C9KCNH2NR1H4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9169199-B2 Cycloalkyl guanidine F1F0-ATPase inhibitors and therapeutic uses thereof LYCERA CORPORATION (US) 2015-10-27 US disclosed
US-9169199-B2 Cycloalkyl guanidine F1F0-ATPase inhibitors and therapeutic uses thereof LYCERA CORPORATION (US) 2015-10-27 US disclosed
WO-2012078867-A2 CYCLOALKYL GUANIDINE F1F0-ATPASE INHIBITORS AND THERAPEUTIC USES THEREOF LYCERA CORPORATION (US) 2012-06-14 WO disclosed